Arfolitixorin - a drug candidate
for treatment of colorectal cancer

Read more

More than 370 000 CRC patients
could be treated
with arfolitixorin

Read more

The global Phase III AGENT study

The AGENT study with arfolitixorin

is ongoing at more than 80 hospitals

in The US, Canada, Europe, Australia and Japan

Read More

See how arfolitixorin
works in cancer cells

See the animation

Previous

Next

Startpage 2

Upcoming Events

  • March 03, 2020 - March 04, 2020
    Carnegie Nordic Healthcare Seminar, Stockholm
    Isofol will attend the "Carnegie Nordic Healthcare Seminar" in Stockholm.
  • March 04, 2020 - March 04, 2020
    Life Science Day, Gothenburg
    Isofol will attend the "Life Science Day" i Gothenburg. The event will also be live broadcast.
  • March 10, 2020 - March 10, 2020
    Fight Cancer Seminar, Stockholm
    Isofol will attend the "Fight Cancer Seminar" in Stockholm, arranged by RedEye. The event will also be live broadcast.